Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

IND accepted for clinical testing of Moli-1901 for dry eye syndrome

March 18, 2005

Miravant plans confirmatory phase III study for Photrex

March 17, 2005

Avastin shows promise for wet AMD

March 14, 2005

Retaane safe in patients with macular degeneration

March 14, 2005

RNAi therapeutic shows potential for AMD in animal model

March 8, 2005

Positive preliminary phase II data for Evizon in AMD

March 8, 2005

OccuLogix cleared to begin crossover studies of RHEO system for dry AMD

March 3, 2005

First patient treated in phase I advanced AMD study of Litx

March 1, 2005

GenVec expands testing of AdPEDF for AMD

Feb. 24, 2005

Enrollment targets met in two phase II studies of squalamine for AMD

Feb. 17, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...